about
Genomics research and malaria control: great expectationsThe role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sicknessHandling uncertainty in dynamic models: the pentose phosphate pathway in Trypanosoma bruceiVirtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase.Aryl phosphoramidates of 5-phospho erythronohydroxamic acid, a new class of potent trypanocidal compounds.Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasisPhylogenetic analysis of rubella viruses identified in Uganda, 2003-2012.Clinical profiles, disease outcome and co-morbidities among T. b. rhodesiense sleeping sickness patients in Uganda.Community engagement strategies for genomic studies in Africa: a review of the literature.Interleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness.Synthesis and biological evaluation of phosphate prodrugs of 4-phospho-D-erythronohydroxamic acid, an inhibitor of 6-phosphogluconate dehydrogenase.Population genetic structure and temporal stability among Trypanosoma brucei rhodesiense isolates in UgandaRoles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance.The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.Characterization and developmentally regulated localization of the mitochondrial carrier protein homologue MCP6 from Trypanosoma brucei.Metabolic Profiling of Central Nervous System Disease in Trypanosoma brucei rhodesiense infection.Relationship between Trypanosoma brucei rhodesiense genetic diversity and clinical spectrum among sleeping sickness patients in Uganda.Comparative diagnostic and analytical performance of PCR and LAMP-based trypanosome detection methods estimated using pooled whole tsetse flies and midguts.A doubly inducible system for RNA interference and rapid RNAi plasmid construction in Trypanosoma brucei.A new erythrose 4-phosphate dehydrogenase coupled assay for transketolase.N-Benzyloxycarbonyl-S-(2,4-dinitrophenyl)glutathione dibutyl diester is inhibitory to melarsoprol resistant cell lines overexpressing the T. bruceiMRPA transporter.No evidence for association between APOL1 kidney disease risk alleles and Human African Trypanosomiasis in two Ugandan populations.Transketolase in Trypanosoma bruceiNo evidence for association with APOL1 kidney disease risk alleles and Human African Trypanosomiasis in two Ugandan populationsDown-Regulating Gene Expression by RNA Interference in Trypanosoma bruceiEvidence of population specific selection inferred from 289 genome sequences of Nilo-Saharan and Niger-Congo linguistic groups in Africa
P50
Q24806742-F9695028-D3D2-4BBF-BBFF-1FA79BC146F1Q26775041-0085FFA1-5DBD-4151-A667-DBB489CC098CQ28536028-79671374-7B8F-42D3-A764-C469944FADD3Q33624493-455A9A3B-C54F-4FA4-AC30-ADB1B8C1643CQ33643365-52EA556A-C033-4734-93C2-AFC65E85DE9DQ33751576-5FEBA307-BBFD-459D-B3E8-43EBE31B7220Q34728936-76513447-5809-4A23-8D5B-7DA19BF1F4CFQ35126176-92FFEFE7-D8D1-44EF-B0F0-CE541CF2DBDFQ35530726-B3F3CD37-58A2-458E-9889-F136E6067B72Q35668603-E315E48A-C6E6-4E74-8795-DDB4F9509625Q36470382-C7D344F2-1708-4D7B-8FFA-6AFB9744A947Q36867056-5D68EBBE-774E-4C54-9247-1028BA969462Q40243220-96956B4E-0E7C-46BE-9E94-A89A34D00749Q40341001-B5EB43DE-6BC0-4B19-9ABF-FC18795E098EQ41966973-3847E281-C943-4FC2-8DC1-3623B24C76C9Q41996448-B43A5B14-49B8-4656-B215-838989EFCE8AQ42617786-44E572AC-8447-498C-9384-98DCE239FA86Q43936849-AB0065BE-5D05-4637-825C-4EFB790A92AFQ45195454-560CE9B3-EC56-4DFC-8D9C-5E48551BB281Q46870889-DC79B299-FFD8-423A-878B-13754F8BA6A2Q50887696-000003D3-6D46-4CC6-A8E2-17295575DB3CQ52374785-2C5DA360-0329-4811-BE58-8CD63AC7639FQ56840521-27FD432D-43C0-4341-B1FE-6DE1F0ADE5EBQ58853512-C6379EAA-4611-4745-8D27-36E54BCD7A68Q58866421-1C43C87D-1C77-4B85-A78C-89EAB1EAB5BDQ64140295-C6B34147-AB72-41C0-BE09-CEE058F0AB39
P50
name
Vincent Pius Alibu
@en
type
label
Vincent Pius Alibu
@en
prefLabel
Vincent Pius Alibu
@en